Skip to main content
. 2023 Sep 8;37:101005. doi: 10.1016/j.ymgmr.2023.101005

Table 2.

Patient characteristics and causes of death in the neuronopathic and non-neuronopathic groups.

Neuronopathic Group (n = 100) Non-neuronopathic Group (n = 51)
Male
n (%) 99 (99.0) 50 (98.0)



Age at Onset of Symptoms, years
n 92 47
Median (P10, P90) 1.5 (0.3, 3.0) 2.0 (0.3, 4.5)
Mean (SD) 1.5 (1.04) 2.2 (1.65)



Age at Diagnosis, years
n 97 50
Median (P10, P90) 3.0 (1.4, 5.3) 4.0 (1.0, 7.4)
Mean (SD) 3.2 (1.53) 4.1 (2.41)



Age at Last Visit, years
n 100 51
Median (P10, P90) 15.7 (12.0, 19.9) 17 (12.6, 21.5)
Mean (SD) 15.8 (3.03) 17.0 (3.24)



Age at First Cognitive Impairment Assessment, years
n 100 51
Median (P10, P90) 4.7 (1.8, 9.7) 6.9 (3.6, 10.2)
Mean (SD) 5.1 (2.92) 6.9 (2.61)



Age at ERT Start, years
n 94 47
Median (P10, P90) 6.5 (2.9, 10.1) 6.7 (2.7, 9.2)
Mean (SD) 6.6 (2.60) 6.4 (2.68)



Functional Classification by Clinical Impression at Last Visit
n 74 41
Normal (IQ >70), n (%) 2 (2.7) 39 (95.1)
Mild/Moderate (IQ 30–70), n (%) 22 (29.7) 2 (4.9)
Severe/Profound (IQ <30), n (%) 50 (67.6) 0 (0.0)
Patients receiving ERT, n (%) 94 (94.0) 47 (92.2)



Number of Different Types of Procedures per Patienta
n 88 49
Median (P10, P90) 3 (1, 6) 3 (1, 7)



Total Number of Procedures per Patienta
n 88 49
Median (P10, P90) 4 (1, 10) 5 (2, 11)



Age at First Procedure, yearsa
n 86 45
Median (P10, P90) 2.5 (0.2, 6.8) 2.2 (0.2, 5.1)
Mean (SD) 3.0 (2.52) 2.5 (1.95)
Deceased, n (%) 47 (47.0) 1 (2.0)



Cause of Death, n (%)
Respiratory Failure 15 (31.9) 0 (0.0)
Cardiac Failure 8 (17.0) 0 (0.0)
Cardiorespiratory Failure 6 (12.8) 0 (0.0)
Infection 6 (12.8) 1 (100)
Renal Failure 1 (2.1) 0 (0.0)
Status Epilepticus or Seizure 1 (2.1) 0 (0.0)
Multiple Organ Failure 1 (2.1) 0 (0.0)
Unknown 9 (19.1) 0 (0.0)
a

Only procedures performed before patients' 10th birthdays were included. ERT, enzyme replacement therapy; IQ, intelligence quotient; P10, 10th percentile; P90, 90th percentile; SD, standard deviation.